A genetic risk score improves risk stratification for anticoagulation-related intracerebral hemorrhage

Author:

Mayerhofer ErnstORCID,Parodi LiviaORCID,Prapiadou SavvinaORCID,Malik Rainer,Rosand JonathanORCID,Georgakis Marios K,Anderson Christopher D

Abstract

AbstractBackgroundIntracerebral hemorrhage (ICH) is the most devastating adverse outcome for patients on anticoagulants. Clinical risk scores (CRS) that quantify bleeding risk can guide decision making in situations when indication or duration for anticoagulation is uncertain. We investigated whether integration of a genetic risk score (GRS) into an existing risk factor-based CRS could improve risk stratification for anticoagulation-related ICH.MethodsWe constructed 153 GRS from genome-wide association data of 1,545 ICH cases and 1,481 controls and validated them in 431 ICH cases and 431 matched controls from the population-based UK Biobank. The score that explained the largest variance in ICH risk was selected and tested for prediction of incident ICH in an independent cohort of 5,530 anticoagulant users. A CRS for major anticoagulation-related hemorrhage, based on 8/9 components of the HAS-BLED score, was compared with an enhanced score incorporating an additional point for high genetic risk for ICH (CRS+G).ResultsAmong anticoagulated individuals, 94 ICH occurred over a mean follow-up of 11.9 years. Compared to the lowest GRS tertile, being in the highest tertile was associated with a two-fold increased risk for incident ICH (HR: 2.08 [95% CI 1.22, 3.56]). While the CRS predicted incident ICH with a HR of 1.24 per one point increase (95% CI [1.01, 1.53]), adding a point for high genetic ICH risk led to a stronger association (HR of 1.33 per one point increase, 95% CI [1.11, 1.59]) with improved risk stratification (C-index 0.58 vs. 0.53) and maintained calibration (integrated calibration index 0.001 for both). The new score (CRS+G) showed 20% improvement of high-risk classification among individuals with ICH and a net reclassification improvement of 0.10.ConclusionsAmong anticoagulant users, a prediction score incorporating genomic information is superior to a clinical risk score alone for ICH risk stratification and could serve in clinicaldecision making.

Publisher

Cold Spring Harbor Laboratory

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Polygenic Risk Scores in the Clinic;Neurology;2023-04-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3